• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症患者治疗前实验室值的预后影响。

Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.

机构信息

Department of Otorhinolaryngology, Jena University Hospital, Lessingstrasse 2, 07740 Jena, Germany.

出版信息

J Cancer Res Clin Oncol. 2013 Jan;139(1):171-8. doi: 10.1007/s00432-012-1320-1. Epub 2012 Sep 25.

DOI:10.1007/s00432-012-1320-1
PMID:23007690
Abstract

PURPOSE

The high comorbidity in patients with head and neck cancer (HNC) is mainly caused by the high incidence of tobacco and alcohol abuse and has direct impact on overall survival. We investigated whether HNC and its comorbidity also influence routine laboratory values and whether these values have influence on overall survival.

METHODS

A retrospective cohort of 261 patients with primary squamous cell carcinoma of the oral cavity, pharynx, or larynx diagnosed between 2001 and 2006 with a complete set of pretherapeutic laboratory values was identified. The influence of standard oncological parameters, comorbidity, and each laboratory value on overall survival (OS) was investigated in univariate and multivariate analyses.

RESULTS

Two-thirds of patients were active smokers and about one half reported high alcohol consumption. 40 % of patients had severe comorbidity according to Charlson comorbidity index. The most frequent laboratory pathologies were elevated C-reactive protein (CRP) values (66 %), impaired liver enzymes (30-50 %), decreased urea levels (33 %), leukocytosis (20 %), and anemia (10 %). In multivariate analysis for OS, a comorbidity index ≥5 (Hazard ratio [HR], 2.008; 95 % confidence interval [CI], 1.117-3.610; p = 0.020), high CRP level (HR, 2.469; CI, 1.414-4.310; p = 0.001), and abnormal low red-cell count (HR, 2.525; CI, 1.250-5.102; p = 0.010) were independent prognostic variables.

CONCLUSIONS

Comorbidity reflected by pathologic laboratory values is a major issue in HNC patients. Several pretherapeutic laboratory values have prognostic relevance for overall survival in HNC patients.

摘要

目的

头颈部癌症(HNC)患者的高合并症主要是由烟草和酒精滥用的高发率引起的,这直接影响整体生存率。我们研究了 HNC 及其合并症是否也会影响常规实验室值,以及这些值是否会影响整体生存率。

方法

回顾性分析了 2001 年至 2006 年间诊断为口腔、咽或喉原发性鳞状细胞癌的 261 例患者的队列,这些患者均具有完整的治疗前实验室值。在单变量和多变量分析中,研究了标准肿瘤学参数、合并症以及每个实验室值对总生存率(OS)的影响。

结果

三分之二的患者为活跃吸烟者,约有一半的患者报告有大量饮酒。根据 Charlson 合并症指数,40%的患者患有严重的合并症。最常见的实验室病理包括 C 反应蛋白(CRP)升高(66%)、肝酶异常(30-50%)、尿素水平降低(33%)、白细胞增多(20%)和贫血(10%)。在多变量分析中,OS 的预后因素包括合并症指数≥5(风险比[HR],2.008;95%置信区间[CI],1.117-3.610;p=0.020)、高 CRP 水平(HR,2.469;CI,1.414-4.310;p=0.001)和异常低红细胞计数(HR,2.525;CI,1.250-5.102;p=0.010)。

结论

由病理实验室值反映的合并症是 HNC 患者的一个主要问题。几种治疗前的实验室值对 HNC 患者的整体生存率具有预后意义。

相似文献

1
Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.头颈部癌症患者治疗前实验室值的预后影响。
J Cancer Res Clin Oncol. 2013 Jan;139(1):171-8. doi: 10.1007/s00432-012-1320-1. Epub 2012 Sep 25.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.头颈部鳞状细胞癌根治性治疗中的全身治疗:一项系统评价
J Otolaryngol Head Neck Surg. 2017 Apr 4;46(1):29. doi: 10.1186/s40463-017-0199-x.
4
Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.年龄校正的查尔森合并症指数是高危前列腺癌患者根治性前列腺切除术后长期生存的重要预后因素:一种贝叶斯模型平均法。
J Cancer Res Clin Oncol. 2016 Apr;142(4):849-58. doi: 10.1007/s00432-015-2093-0. Epub 2015 Dec 12.
5
Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.放疗或放化疗治疗的头颈癌患者中肿瘤控制及可见坏死情况的影响
J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. doi: 10.1007/s00432-005-0018-z. Epub 2005 Nov 1.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Head and Neck Soft Tissue Sarcoma Patient: Age and Tumor Region Are Predictive in Disease-Free Survival and Overall Survival.头颈部软组织肉瘤患者:年龄和肿瘤部位与无疾病生存和总生存相关。
J Oral Maxillofac Surg. 2024 Jun;82(6):719-727. doi: 10.1016/j.joms.2024.02.015. Epub 2024 Mar 5.

引用本文的文献

1
Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients.前瞻性队列研究确定口腔和口咽癌患者治疗相关口腔毒性的医学预测因素。
Dent J (Basel). 2024 Apr 1;12(4):89. doi: 10.3390/dj12040089.
2
Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer.一种新型唾液标志物与口腔癌中几种临床预后指标的比较。
Laryngoscope Investig Otolaryngol. 2023 Oct 12;8(6):1547-1556. doi: 10.1002/lio2.1166. eCollection 2023 Dec.
3
The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma.

本文引用的文献

1
Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.血小板增多症:诊断评估、血栓形成风险分层及基于风险的管理策略
Thrombosis. 2011;2011:536062. doi: 10.1155/2011/536062. Epub 2011 Jun 8.
2
Population-based study of competing mortality in head and neck cancer.基于人群的头颈部癌症竞争死亡研究。
J Clin Oncol. 2011 Sep 10;29(26):3503-9. doi: 10.1200/JCO.2011.35.7301. Epub 2011 Aug 15.
3
The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma.
围手术期C反应蛋白在预测上皮性卵巢癌预后中的作用
Cancer Manag Res. 2023 Feb 27;15:233-243. doi: 10.2147/CMAR.S385974. eCollection 2023.
4
Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma.CXCR 家族成员在头颈部鳞状细胞癌中的表达谱和预后价值。
World J Surg Oncol. 2022 Aug 17;20(1):259. doi: 10.1186/s12957-022-02713-z.
5
Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma.血清CRP水平对头颈部鳞状细胞癌的预后影响
Front Oncol. 2022 Jun 29;12:889844. doi: 10.3389/fonc.2022.889844. eCollection 2022.
6
Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer.口腔癌患者血清尿素、肌酐和尿酸的评估
J Clin Med. 2022 Jun 16;11(12):3459. doi: 10.3390/jcm11123459.
7
Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma.非转移性食管鳞状细胞癌患者在根治性同步放化疗期间血小板与淋巴细胞比值及淋巴细胞的影响
J Oncol. 2022 Apr 29;2022:3412349. doi: 10.1155/2022/3412349. eCollection 2022.
8
Comparison of the surgical outcomes of free flap reconstruction for primary and recurrent head and neck cancers: a case-controlled propensity score-matched study of 1,791 free flap reconstructions.比较原发性和复发性头颈部癌游离皮瓣重建的手术结果:1791 例游离皮瓣重建的病例对照倾向评分匹配研究。
Sci Rep. 2021 Jan 27;11(1):2350. doi: 10.1038/s41598-021-82034-5.
9
The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.C 反应蛋白对头颈部鳞状细胞癌患者预后作用的荟萃分析。
Cancer Med. 2020 Dec;9(24):9541-9553. doi: 10.1002/cam4.3520. Epub 2020 Nov 17.
10
The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.治疗前C反应蛋白是接受放疗的口腔和口咽癌患者的一个预后因素。
Cancers (Basel). 2020 Mar 8;12(3):626. doi: 10.3390/cancers12030626.
合并症对喉鳞状细胞癌患者生存的影响。
Acta Otolaryngol. 2011 Aug;131(8):840-6. doi: 10.3109/00016489.2011.564651. Epub 2011 Apr 15.
4
Evaluation of white blood cell count as a possible prognostic marker for oral cancer.评估白细胞计数作为口腔癌潜在预后标志物的情况。
Head Neck Oncol. 2011 Feb 27;3:13. doi: 10.1186/1758-3284-3-13.
5
Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study.术前循环 C 反应蛋白水平可预测口腔鳞状细胞癌的病理侵袭性:一项回顾性临床研究。
Clin Otolaryngol. 2011 Apr;36(2):147-53. doi: 10.1111/j.1749-4486.2011.02274.x.
6
Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review.合并症对实体瘤化疗应用和结局的影响:系统评价。
J Clin Oncol. 2011 Jan 1;29(1):106-17. doi: 10.1200/JCO.2010.31.3049. Epub 2010 Nov 22.
7
C-reactive protein levels: a prognostic marker for patients with head and neck cancer?C反应蛋白水平:头颈部癌症患者的预后标志物?
Head Neck Oncol. 2010 Aug 2;2:21. doi: 10.1186/1758-3284-2-21.
8
[Coagulation factors as potential tumour markers in patients with head and neck carcinomas?].[凝血因子作为头颈癌患者潜在的肿瘤标志物?]
Laryngorhinootologie. 2010 Oct;89(10):612-5. doi: 10.1055/s-0030-1261892. Epub 2010 Jul 13.
9
Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.国际头颈部癌症流行病学(INHANCE)联盟病例对照研究的荟萃分析中,体重指数与头颈部癌症风险的关系。
Int J Epidemiol. 2010 Aug;39(4):1091-102. doi: 10.1093/ije/dyp380. Epub 2010 Feb 1.
10
Predictors of competing mortality in advanced head and neck cancer.晚期头颈部癌症竞争死亡率的预测因素。
J Clin Oncol. 2010 Jan 1;28(1):15-20. doi: 10.1200/JCO.2008.20.9288. Epub 2009 Nov 23.